Provenance Record

Well-structured News piece with clear sections (Overview, What We Know, What We Don't Know, Context). Technical detail is appropriate and accessible. Tone is neutral, framing is measured, and the 'What We Don't Know' section responsibly acknowledges missing information (pricing, timelines, head-to-head clinical comparisons, PCCP status). Word count 767 fits the News category range (400-1200).

{"https://www.globenewswire.com/news-release/2026/04/16/3275385/0/en/Philips-receives-FDA-510-k-clearance-for-Verida-the-world-s-first-AI-powered-detector-based-spectral-CT-advancing-diagnostic-precision-across-clinical-applications.html":"VERIFIED — All 12 claims attributed to this release are directly supported by the source text: FDA 510(k) clearance on April 16, 2026; 145 images per second reconstruction; full exams in under 30 seconds (2x faster); up to 270 exams/day (premium 4 CIRS config); SPI as AI-based deep learning reconstruction engine; SPI clinically evaluated in adults 22+; SPI does not replace professional clinical judgment; clearance scope (radiology, interventional radiology, cardiology, oncology); indications (head, whole-body, cardiac, vascular, all ages, low-dose lung cancer screening); 4DCT and extended FOV limited to treatment/radiation planning; Dan Xu quote; third-generation Nano-panel Precise dual-layer detector.","https://www.globenewswire.com/news-release/2025/11/30/3196599/0/en/Philips-launches-Verida-world-s-first-detector-based-spectral-CT-powered-by-breakthrough-AI-to-advance-diagnostic-precision.html":"PARTIALLY VERIFIED — Supported by source: dramatic dose reduction claim; up to 45% energy consumption reduction; the 45% figure's methodological framing (axial body 3D scan with 80% dose reduction, excluding system preparation energy); 510(k) listed as pending in US at time of launch. NOT SUPPORTED: The article attributes the 'IQon and Spectral CT 7500' model names and the '800 installations / 800 peer-reviewed publications' figures to this release as if they specifically described those two models. The source only references 'Philips' spectral CT' generically; it does not name IQon or Spectral CT 7500. This is a misattribution that needs correction.","https://www.fiercebiotech.com/medtech/ge-healthcare-philips-siemens-spotlight-ai-forward-imaging-rsna-2025":"VERIFIED via Archive.org fallback and WebSearch — FierceBiotech blocks direct WebFetch (403), but the chief:review script successfully retrieved the content via Archive.org, and WebSearch confirmed the article's existence and coverage. The piece covers GE HealthCare, Philips, and Siemens Healthineers competing on AI-integrated scanners at RSNA 2025, discussing AI-forward imaging platforms from all three companies including Siemens' Naeotom Alpha photon-counting CT family. The article's use of this source to support the competitive-landscape framing is appropriate. The mention of GE HealthCare's 'Revolution Apex and Revolution Ascend' is context about GE's CT portfolio rather than a claim requiring direct source support."}

One misattribution flagged (IQon/Spectral CT 7500 attribution in the 'Efficiency claims' paragraph). All other factual claims — FDA clearance date, technical specs (145 images/sec, sub-30-second exams, 270 exams/day), SPI deep learning engine, clinical indications, pediatric SPI exclusion, the 45% energy reduction with methodological caveats — are accurately attributed to the correct sources.

Strong submission on a genuinely newsworthy FDA clearance, with tight structure, good hedging, and careful source use across 11 out of 12 claims. Blocked on one misattribution that wrongly ties specific Philips product model names (IQon, Spectral CT 7500) to a press release that does not mention them. This is a narrow, easily fixable issue — not a systemic problem with the piece.